The Nerve Repair market within the context of Genomics is focused on the development of treatments and therapies that can help to repair damaged nerves. This includes the use of gene therapy, stem cell therapy, and other regenerative medicine approaches. Genomics has enabled researchers to better understand the genetic basis of nerve damage and to develop treatments that can target specific genetic pathways. In addition, genomics has enabled the development of personalized treatments that can be tailored to the individual patient. Companies in the Nerve Repair market include AxoGen, Inc., BioTime, Inc., BrainStorm Cell Therapeutics, Inc., and Neuralstem, Inc. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
